SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Otsuka Holdings Co., Ltd. OTSKF OTC

Other OTC • Healthcare • Drug Manufacturers - General • JP • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Otsuka Holdings Co., Ltd. (OTSKF) is a Drug Manufacturers - General company in the Healthcare sector, currently trading at $69.70. It has a SharesGrow Score of 86/100, indicating a strong investment profile with 5 out of 7 criteria passed.

Financials: revenue is $2.5T, +12.5%/yr average growth. Net income is $363.5B, growing at +59.6%/yr. Net profit margin is 14.7% (healthy). Gross margin is 71.7% (+4.5 pp trend).

Balance sheet: total debt is $307.3B against $3.0T equity (Debt-to-Equity (D/E) ratio 0.1, conservative). Current ratio is 2.17 (strong liquidity). Debt-to-assets is 7.3%. Total assets: $4.2T.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 88/100 (Pass), Future ?/100 (Fail), Income 55/100 (Partial).

OTSKF SharesGrow Score Overview

89/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 90/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 100/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 88/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — OTSKF

OTSKF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

OTSKF: +12.5%/yr revenue is, +59.6%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

OTSKF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet OTSKF: Debt-to-Equity (D/E) ratio 0.1 (conservative), Current ratio is 2.17 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

OTSKF: Gross margin is 71.7% (+4.5 pp trend), $37B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 88/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

OTSKF: Net profit margin is 14.7%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range44.4-72.215

Volume143

Avg Volume (30D)31

Market Cap$36.81B

Beta (1Y)-0.08

Dividend Yield$0.9100

Share Statistics

EPS (TTM)685.44

Shares Outstanding$530.1M

IPO Date2012-08-03

Employees35,338

CEOMakoto Inoue

Financial Highlights & Ratios

Revenue (TTM)$2.47T

Gross Profit$1.77T

EBITDA$529.06B

Net Income$363.47B

Operating Income$412.79B

Total Cash$535.11B

Total Debt$307.31B

Net Debt$-227.81B

Total Assets$4.2T

Price / Earnings (P/E)0.1

Price / Sales (P/S)0.01

Analyst Forecast

Company Info

CountryJP

ExchangeOther OTC

CurrencyUSD

ISINJP3188220002

Price Chart

OTSKF

Otsuka Holdings Co., Ltd. ↗ · Other OTC

Healthcare • Drug Manufacturers - General

44.40 52WK RANGE 72.22

People Also View

Eli Lilly and Company

Johnson & Johnson

Merck & Co., Inc.

Bristol-Myers Squibb Company

Astellas Pharma Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message